Bank of Montreal’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,218
Closed -$63K 4340
2021
Q1
$63K Sell
2,218
-38,970
-95% -$1.23M ﹤0.01% 3605
2020
Q4
$1.54M Sell
41,188
-1,346
-3% -$47.3K ﹤0.01% 1971
2020
Q3
$1.32M Buy
42,534
+6,416
+18% +$142K ﹤0.01% 1841
2020
Q2
$646K Buy
+36,118
New +$521K ﹤0.01% 2136
2020
Q1
Sell
-4,838
Closed -$67K 4403
2019
Q4
$67K Buy
4,838
+1,828
+61% +$27.1K ﹤0.01% 3696
2019
Q3
$46K Buy
3,010
+545
+22% +$9.7K ﹤0.01% 3662
2019
Q2
$49K Buy
2,465
+2,462
+82,067% +$40.9K ﹤0.01% 3706
2019
Q1
$0 Sell
3
-397
-99% -$6.12K ﹤0.01% 4533
2018
Q4
$6K Buy
400
+205
+105% +$2.72K ﹤0.01% 4025
2018
Q3
$3K Buy
195
+19
+11% +$364 ﹤0.01% 4241
2018
Q2
$3K Sell
176
-7,460
-98% -$126K ﹤0.01% 4257
2018
Q1
$144K Sell
7,636
-2,198
-22% -$42.8K ﹤0.01% 2793
2017
Q4
$150K Sell
9,834
-392,600
-98% -$5.79M ﹤0.01% 2810
2017
Q3
$6.02M Buy
+402,434
New +$3.78M 0.01% 1080

Other funds holding KURA

Bank of Montreal's KURA Position: Q2 2021 in Review

Bank of Montreal sold out of Kura Oncology (KURA) in Q2 2021, closing a stake of 2,218 shares — an estimated $63K sold.

Bank of Montreal first reported a position in KURA in Q3 2017 and held it in 14 quarters. The position peaked at $6.02M in Q3 2017. 171 funds tracked by Wall St. Rank hold KURA as of Q2 2021.

  • Bank of Montreal reported no remaining Kura Oncology position as of Q2 2021 after selling out during the quarter.
  • Bank of Montreal sold 2,218 Kura Oncology shares in Q2 2021, an estimated $63K.
  • Bank of Montreal first reported a position in Kura Oncology in Q3 2017 and held it in 14 quarters.
  • Bank of Montreal's Kura Oncology position peaked at $6.02M in Q3 2017.
  • 171 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2021.

Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.